Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2018-02-12 AGM Information
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Result of General Meeting - 12 February 2018
AGM Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number : 5785E) from Dechra Pharmaceuticals PLC, dated February 12, 2018. The core content reports the 'Results of General Meeting,' detailing that the resolutions put to shareholders, specifically concerning the approval of an acquisition, were passed. It includes a detailed table of proxy votes received for and against the resolutions. This content directly relates to the official results of a shareholder vote at a general meeting. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). Although it is an RNS announcement, the specific content is highly indicative of DVA, which takes precedence over the general RNS fallback.
2018-02-12 English
Result of General meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled 'Results of General Meeting' and provides a detailed breakdown of proxy votes for specific resolutions (Acquisition of AST Farma B.V. and Le Vet Beheer B.V.). It explicitly lists the number of votes 'For', 'Against', and 'Withheld' for each resolution. This aligns perfectly with the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2018-02-12 English
Genral meeting resolutions
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document explicitly states it contains 'COPY RESOLUTIONS' passed at a 'general meeting of the Company' on '12 February 2018'. It details 'ORDINARY RESOLUTIONS' (Acquisition, Allotment) and 'SPECIAL RESOLUTIONS' (Disapplication of pre-emption resolutions). This content—formal resolutions passed by shareholders at a meeting—is characteristic of materials presented or finalized following an Annual General Meeting (AGM) or an Extraordinary General Meeting (EGM). Since the resolutions relate to major corporate actions (acquisition approval, share allotment authority), and the document is a formal record of shareholder voting outcomes on these matters, it aligns best with the context of AGM materials or the formal declaration of voting results. Given the structure detailing the resolutions passed, 'Declaration of Voting Results & Voting Rights Announcements' (DVA) is the most precise fit for documenting the outcome of shareholder votes, although it is closely related to AGM materials (AGM-R). Since it is a record of the resolutions *passed* at the meeting, DVA is selected over AGM-R which often implies presentations or notices.
2018-02-12 English
Notification of Major Holdings
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an 'RNS Number'. It details changes in voting rights percentages (crossing thresholds from 10.54% to 9.99%) for the issuer Dechra Pharmaceuticals PLC, filed by FMR LLC. This type of mandatory disclosure regarding significant changes in share ownership thresholds is classified as a Major Shareholding Notification. The presence of the RNS number suggests it was also released via the Regulatory News Service, but the core content is the major holding change notification.
2018-01-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly contains the header "RNS Number : 3846D" and the footer "This information is provided by RNS The company news service from the London Stock Exchange". The content is a "TR-1: Standard form for notification of major holdings", which details changes in share ownership thresholds by BlackRock, Inc. This type of mandatory disclosure regarding significant changes in shareholdings is a specific regulatory filing. While it relates to share ownership, the specific form (TR-1) and the RNS source strongly point towards a general regulatory announcement category, which aligns best with 'Regulatory Filings' (RNS) as the primary classification, or potentially 'Major Shareholding Notification' (MRQ). Given the explicit RNS branding and the structure being a standard regulatory notification form, RNS is the most appropriate general classification for this type of filing, although MRQ is also highly relevant. Since RNS is defined as the fallback for miscellaneous regulatory filings that don't fit elsewhere, and this is a standard regulatory form submission, I will classify it as RNS, as it is a direct notification to the exchange via the RNS system.
2018-01-30 English
Admission of Placing Shares & Total Voting Rights
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS The company news service from the London Stock Exchange'. The content details the admission of placing shares and confirms the 'total number of Ordinary Shares with voting rights' following a recent placing announcement. This type of mandatory disclosure regarding changes in total voting rights and issued share capital, especially when originating from RNS, strongly suggests a regulatory announcement. While it relates to share capital changes (SHA), the primary function here is the mandatory notification of the resulting total voting rights figure, which fits best under the general regulatory announcement category (RNS) or potentially a specific capital change notification. Given the explicit RNS source and the nature of the disclosure (total voting rights denominator), RNS is the most appropriate general classification for this type of market update filing that isn't a full financial report or a specific transaction report like POS or SHA, although it touches upon share capital. Since the document is short and is a direct regulatory update provided via RNS, I will classify it as RNS.
2018-01-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.